Nineteen states, D.C. sue HHS over gender-affirming care ...

What’s Happening

Here’s the thing: Have sued HHS, calling an RFK Jr.

Declaration that rejected gender-affirming care an overreach of its authority. First Opinion First Opinion Proposed HHS rule on gender-affirming care radically expands use of Medicare, Medicaid as policy weapons By Carmel Shachar and Nicole Huberfeld Health Health 3 drug policy questions to watch in 2026 By Lev Facher Politics Politics STAT Plus: The 3 biggest issues to watch in vaccine policy in 2026 By Daniel Payne First Opinion First Opinion What giving flu shots backstage taught me about public health By Ram Koppaka Pharma Pharma STAT Plus: Major pharma companies may avoid Medicare experiments’ forced price cuts By John Wilkerson and Elaine Chen STAT Plus: FDA voucher program has become vehicle for political interference in drug review decisions, staffers say By Lizzy Lawrence STAT Plus: I’m the former head of Pfizer R&D. (wild, right?)

I’m worried about biopharma’s future By John L.

Why This Matters

LaMattina STAT Plus: The Worst Biopharma CEO of 2025 made decisions with tragic consequences By Adam Feuerstein STAT Plus: Data on Humana’s clinics looked dismal.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

Are you here for this or nah?